119 related articles for article (PubMed ID: 9744080)
1. Metabolic effects of thiopurine derivatives against human CCRF-CEM leukaemia cells.
Shi RZ; Lyons SD; Christopherson RI
Int J Biochem Cell Biol; 1998 Aug; 30(8):885-95. PubMed ID: 9744080
[TBL] [Abstract][Full Text] [Related]
2. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.
Coulthard SA; Redfern CP; Vikingsson S; Lindqvist-Appell M; Skoglund K; Jakobsen-Falk I; Hall AG; Taylor GA; Hogarth LA
Mol Cancer Ther; 2011 Mar; 10(3):495-504. PubMed ID: 21282358
[TBL] [Abstract][Full Text] [Related]
4. Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samples.
Okamoto H; Tanaka Y; Shibagaki Y; Kuronuma S; Miyatani Y; Umeda S; Mishiro-Sato E; Takeuchi O; Hattori S; Kobayashi T; Okuwaki M
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():123993. PubMed ID: 38246006
[TBL] [Abstract][Full Text] [Related]
5. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.
Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG
Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420
[TBL] [Abstract][Full Text] [Related]
6. Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
Brouwer C; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ; Bökkerink JP; Hoogerbrugge PM; van Wering ER; Veerman AJ; De Abreu RA
Clin Chim Acta; 2005 Nov; 361(1-2):95-103. PubMed ID: 15990089
[TBL] [Abstract][Full Text] [Related]
7. CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
Huynh T; Murray J; Flemming CL; Kamili A; Hofmann U; Cheung L; Roundhill EA; Yu DMT; Webber HT; Schwab M; Henderson MJ; Haber M; Norris MD; Fletcher JI
Biochem Pharmacol; 2020 Feb; 172():113770. PubMed ID: 31862449
[TBL] [Abstract][Full Text] [Related]
8. Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites.
Elgemeie GH
Curr Pharm Des; 2003; 9(31):2627-42. PubMed ID: 14529546
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia.
Adamson PC; Poplack DG; Balis FM
Leuk Res; 1994 Nov; 18(11):805-10. PubMed ID: 7967706
[TBL] [Abstract][Full Text] [Related]
10. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
12. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
[TBL] [Abstract][Full Text] [Related]
13. Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Blom HJ; Lambooy LH; Vogels-Mentink TM; de Graaf-Hess AC; van Raay-Selten B; Trijbels FJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):163-8. PubMed ID: 7998928
[TBL] [Abstract][Full Text] [Related]
14. Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate.
Giverhaug T; Loennechen T; Aarbakke J
Biochem Pharmacol; 1998 May; 55(10):1641-6. PubMed ID: 9634000
[TBL] [Abstract][Full Text] [Related]
15. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mannose incorporation into glycoproteins and dolichol-linked intermediates of Sarcoma 180 cells by 6-methylmercaptopurine ribonucleoside.
Sokoloski JA; Sartorelli AC
Int J Cancer; 1987 Jun; 39(6):764-8. PubMed ID: 3583454
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of 5-phosphoribosyl-1-pyrophosphate in human CCRF-CEM leukaemia cells treated with antifolates.
Kamal MA; Christopherson RI
Int J Biochem Cell Biol; 2004 Mar; 36(3):545-51. PubMed ID: 14687931
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells.
Drake S; Burns RL; Nelson JA
Chem Biol Interact; 1982 Jul; 41(1):105-15. PubMed ID: 6807556
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of inhibition of amido phosphoribosyltransferase from mouse L1210 leukemia cells.
Schoettle SL; Crisp LB; Szabados E; Christopherson RI
Biochemistry; 1997 May; 36(21):6377-83. PubMed ID: 9174353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
